The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 08, 2010

Filed:

May. 08, 2007
Applicants:

Hengmiao Cheng, San Diego, CA (US);

Jingrong Jean Cui, San Diego, CA (US);

Jacqui Elizabeth Hoffman, San Diego, CA (US);

Lei Jia, San Diego, CA (US);

Mary Catherine Johnson, San Diego, CA (US);

Robert Steven Kania, San Diego, CA (US);

Phuong Thi Quy Le, San Diego, CA (US);

Mitchell David Nambu, San Diego, CA (US);

Mason Alan Pairish, San Diego, CA (US);

Hong Shen, San Diego, CA (US);

Michelle Bich Tran-dubé, San Diego, CA (US);

Inventors:

Hengmiao Cheng, San Diego, CA (US);

Jingrong Jean Cui, San Diego, CA (US);

Jacqui Elizabeth Hoffman, San Diego, CA (US);

Lei Jia, San Diego, CA (US);

Mary Catherine Johnson, San Diego, CA (US);

Robert Steven Kania, San Diego, CA (US);

Phuong Thi Quy Le, San Diego, CA (US);

Mitchell David Nambu, San Diego, CA (US);

Mason Alan Pairish, San Diego, CA (US);

Hong Shen, San Diego, CA (US);

Michelle Bich Tran-Dubé, San Diego, CA (US);

Assignee:

Pfizer Inc., New York, NY (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 471/00 (2006.01); C07D 487/00 (2006.01); C07D 491/00 (2006.01); C07D 495/00 (2006.01); C07D 497/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The invention relates to compounds of the formula I or a pharmaceutically acceptable salt thereof, wherein R, R, Rand Rare as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.


Find Patent Forward Citations

Loading…